Form 8-K - Current report:
SEC Accession No. 0001213900-25-019439
Filing Date
2025-03-03
Accepted
2025-03-03 16:30:25
Documents
13
Period of Report
2025-02-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea023260201-8k_aditxt.htm   iXBRL 8-K 32406
  Complete submission text file 0001213900-25-019439.txt   208328

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE adtx-20250228.xsd EX-101.SCH 3018
3 XBRL LABEL FILE adtx-20250228_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE adtx-20250228_pre.xml EX-101.PRE 22361
15 EXTRACTED XBRL INSTANCE DOCUMENT ea023260201-8k_aditxt_htm.xml XML 3786
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 25698476
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)